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Summary
 
Cytokine expression in lymph nodes from cattle inoculated intranasally with
 
Mycobacterium bovis
 
 was compared to that of non-infected animals using
real-time polymerase chain reaction. The effect of 
 
M. bovis
 
 infection, 4
months post-challenge, was to suppress the expression of anti-inflammatory
cytokines interleukin (IL)-4 and IL-10 as well as the pro-inflammatory
cytokines tumour necrosis factor (TNF) and IL-6. Expression of interferon
(IFN)-
 
γ
 
 and IL-12 was maintained. Animals vaccinated with bacille Calmette–
Guérin responded differently to challenge with 
 
M. bovis
 
. In particular, no
decrease in expression of IL-4 or IL-6 was observed following challenge of vac-
cinated animals and decreased IFN-
 
γ
 
 was detected. Also, vaccinated animals
had higher levels of IL-4 and IL-10 transcripts compared to unvaccinated ani-
mals following challenge. These changes in cytokine expression levels led to a
significant shift in the IFN-
 
γ
 
/IL-4 or IFN-
 
γ
 
/IL-10 ratio within the lymph node
following challenge. Challenged animals generally showed a strong Th1 bias
that was not seen in animals vaccinated prior to challenge. An inverse corre-
lation between the level of pathology and bacterial load within the lymph
node and the expression of IL-4, IL-10 and TNF was also observed. These
results suggest that in the lymph nodes of cattle with established tuberculosis
and a persisting bacterial infection, maintenance of the pro-inflammatory
response in combination with a suppressed anti-inflammatory response may
control the infection but contribute to host-induced tissue damage. Vaccina-
tion, which reduces the bacterial load and consequently the IFN-
 
γ
 
 response,
may result in less suppression of anti-inflammatory cytokines.
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Introduction
 
Bovine tuberculosis (TB), caused by 
 
Mycobacterium bovis
 
,
persists both in countries with active diagnostic and eradi-
cation policies and in those that lack these measures. 
 
M.
bovis
 
 bacille Calmette–Guérin (BCG), an attenuated form of
 
M. bovis
 
 utilized as a vaccine against TB in humans, shows
variable efficacy (0–80%), due possibly to prior exposure to
environmental mycobacteria [1,2]. A similar situation has
been described in cattle (reviewed in [3]). Infection with
mycobacteria such as 
 
M. bovis
 
 results in the formation of
granulomas, comprised of a core of infected and killed mac-
rophages (M
 
φ
 
) surrounded and infiltrated by T lymphocytes
[4–7], within the lungs and lymph nodes. The granuloma
acts to control and constrict the spread of infection, but also
results in significant tissue damage [8,9].
Immunity to mycobacteria is dependent mainly on a cell-
mediated response involving M
 
φ
 
, dendritic cells and an
adaptive T cell response. The functions of these cells are
modulated by cytokines, and the close proximity of cells
within the granuloma is thought to facilitate the immune
responses induced [10]. The roles played by cytokines vary
widely; some are pro-inflammatory, activating cells of the
immune system to kill mycobacteria and inducing a type I
immune response, while others, such as interleukin (IL)-4
and IL-10, are anti-inflammatory, down-regulating the pro-
inflammatory immune response to control tissue damage
[11–13]. Of the pro-inflammatory cytokines, interferon
(IFN)-
 
γ
 
 is considered to be critical for the control of myco-
bacterial infection [13,14], although others such as IL-12, IL-
6 and tumour necrosis factor (TNF) also play a significant
role [15–19].
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Several studies have determined cytokine levels at the
granulomatous site in humans infected with pathogenic
mycobacteria [7,20–25]. These studies include quantitative
and semiquantitative measurements of cytokine RNA in
tuberculous patients compared to healthy controls [7,20]
and immunohistochemical studies of protein levels [24,25].
Results indicated that the expression or presence of IL-12,
TNF and IFN-
 
γ
 
 was common [7,20–22,25], although one
study detected no TNF or IFN-
 
γ
 
 protein in samples from
tuberculous lesions [24]. IL-10 [20] and transforming
growth factor (TGF)-
 
β
 
 [25] were also detected in tubercu-
lous lesions, but detection of IL-4, indicative of a Th2
response, was variable [7,20–22,24,25]. By comparing cytok-
ine expression in tuberculous tissue directly to that of con-
trols, a reduction in levels of IL-4 and IL-10 in patients with
TB has been demonstrated [7,25]. This suggests that, at least
in humans, the immune response to pathogenic mycobacte-
ria in the lung [21–25] and in the lymph node [7,20] is pre-
dominantly of the pro-inflammatory Th1 type, promoting
killing of infected cells and extracellular bacteria.
Differences in the pathogenicity of 
 
M. tuberculosis
 
, the
causative agent of human TB, and 
 
M. bovis
 
, manifested in the
restricted host-range of 
 
M. tuberculosis
 
, will be reflected in
the host-specific immune response to them. Thus, although
many of the principles established for 
 
M. tuberculosis
 
 will
hold for 
 
M. bovis
 
, there must be differences that affect each
species’ ability to infect their hosts. The cow provides an
ideal model for study of 
 
M. bovis
 
 as, unlike the mouse as a
model for TB, it is the natural and primary host and develops
granulomas that are highly similar in structure to those seen
in humans [5,26,27]. Following intranasal exposure of cattle,
lymph nodes in the head are known to display lesions char-
acteristic of TB [26,28].
A key objective of this study was to assess quantitatively
the expression of key pro- and anti-inflammatory cytokines,
known to be involved in immunity to TB, in bovine tissues
infected with 
 
M. bovis
 
. Immune responses were assessed 4
months after challenge, when the acute phase of infection
was under control and chronic disease, which occurs in the
face of an ongoing immune response, was developing. A sec-
ond aspect of this study was to determine cytokine expres-
sion levels in the tissues of animals vaccinated with BCG
prior to challenge. Such animals are known to exhibit a
degree of resistance to TB [29–32]. It was proposed that a
quantitative examination of the cytokines in the lymph
nodes that drain the site of challenge would reveal differ-
ences in these groups of animals. This 
 
in vivo
 
 data would
complement but may also differ from that obtained from
studies involving restimulation of lymphocytes 
 
in vitro
 
.
Results indicate that the infected lymph nodes of animals
challenged with 
 
M. bovis
 
 show suppression of IL-4, IL-6, IL-
10 and TNF expression when compared to healthy animals,
but no change was seen in the expression levels of IL-12 or
IFN-
 
γ
 
. Vaccination with BCG prior to infection altered the
response to challenge; in particular, no decrease in IL-4 or
IL-6 levels were detected but we did observe a decrease in
IFN-
 
γ
 
 levels.
 
Materials and methods
 
Mycobacterial culture, experimental animals and 
isolation of samples
 
Procedures for the culture and quantification of bacteria
have been described previously [29]. All experiments con-
formed to local and national guidelines on the use of exper-
imental animals and category III infectious organisms. The
animals selected for this study consisted of the following four
groups: (1) unvaccinated animals infected with 
 
M. bovis
 
 
 
−
 
 four animals challenged intranasally and shown to have
lesions at necroscopy; (b) unvaccinated unchallenged
animals 
 
−
 
 three animals not exposed to 
 
M. bovis
 
; (c) vacci-
nated animals infected with 
 
M. bovis
 
 
 
−
 
 five animals vacci-
nated with BCG and challenged intranasally; and (d)
vaccinated unchallenged animals 
 
−
 
 three animals vaccinated
with BCG but not challenged with 
 
M. bovis
 
. All animals were
age-matched and of the same breed. The challenged animals
have  been  reported  previously  [29].  Briefly,  vaccination
of challenged animals was carried out at 1 day old with 10
 
6
 
BCG Pasteur, and intranasal challenge at 12 weeks with
1·3 
 
×
 
 10
 
4
 
 M. bovis
 
 (AF2122/97) [33]. Control animals were
vaccinated with BCG Pasteur at 6 months of age. Pathology
and bacteriology relevant to tissues used are summarized in
Table 1. At necroscopy, 4 months after intranasal exposure,
vaccinated animals had significantly lower numbers of bac-
teria and lesions, where present, were less severe [29].
 
RNA extraction and synthesis of cDNA
 
One parotid, one submandibular and both retropharyngeal
lymph nodes were removed from all animals post mortem.
Tissues were dissected into cubes approximately 0·4 cm
 
3
 
 for
RNA extraction and stored in 4 
 
M
 
 guanidine thiocyanate
(GTC)  for  24 h  at  4
 
°
 
C,  followed  by  long-term  storage  at
 
−
 
20
 
°
 
C. Tissue samples, one per lymph node, were homoge-
nized in buffer RNeasy lysis buffer (RLT; Qiagen, Hilden,
Germany) using a Mini-BeadBeater and 1 mm zirconia silica
beads (BioSpec Products, Inc., Bartlesville, OK, USA). Sam-
ples were homogenized further using Qiashredders
(Qiagen). RNA extractions were carried out using the RNe-
asy mini kit (Qiagen). RNA yields and quality were deter-
mined using an Ultrospec 2100 pro spectrophotometer
(Amersham Biosciences, Piscataway, NJ, USA), and con-
firmed by agarose gel electrophoresis. RNA was treated with
RNase-free DNase I [Ambion (Europe) Ltd, Cambridge,
UK] to remove any contaminating genomic DNA prior to
reverse transcription into cDNA. Reverse transcription of
200 ng of RNA per sample was performed using 200 units
SuperScript II reverse transcriptase, 500 ng oligo dT, 0·5 m
 
M
 
deoxyribonucleoside triphosphate (dNTPs), 10 m
 
M
 
 dithio-
threitol (DTT), 1
 
×
 
 first-strand buffer and 40 units RNAsin
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(Invitrogen Ltd, Carlsbad, CA, USA). cDNA was made up to
a total volume of 50 
 
μ
 
l by the addition of 30 
 
μ
 
l endonu-
clease-free water prior to use.
 
Primers and 
 
Taq
 
Man® probes
 
Primers, based on the published sequences of bovine genes,
were designed to span introns where possible to ensure dis-
crimination between cDNA and genomic DNA primers and
probes for 
 
Taq
 
Man® analysis, with the exception of IL-4 and
IFN-
 
γ
 
, have been tested previously at the Institute for Animal
Health [34,35] and were synthesized by PE oligofactory
(Applied Biosystems, CA, USA), Sigma-Genosys Ltd
(Haverhill, UK) or Eurogentec Ltd (Romsey, UK). Primer
sequences for IL-4 were as follows: forward primer
5
 
′
 
-GCCACACGTGCTTGAACAAA-3
 
′
 
, reverse primer 5
 
′
 
-
TCTTGCTTGCCAAGCTGTTG-3
 
′
 
, probe 5
 
′
 
-TCCTGGGC
GGACTTGACAGGAATC-3
 
′
 
, and were designed by Dr D.
Werling (Royal Veterinary College). The primers and
probe used for analysis of IFN-
 
γ
 
 were kindly provided by
Dr G. Taylor and Dr J. F. Valarcher (Institute for Animal
Health) prior to publication. Probes for 
 
Taq
 
Man® analysis
were labelled at the 5
 
′
 
 end with the reporter dye FAM (6-
carboxyfluorescein) and at the 3
 
′
 
 end with the quencher dye
TAMRA (6-carboxytetramethyl-rhodamine).
 
Real-time 
 
Taq
 
Man® polymerase chain reaction (PCR) 
for quantification of cytokine cDNA
 
Quantitative PCR was carried out using 
 
Taq
 
Man® Universal
PCR Mastermix (Applied Biosystems), with 100 ng cDNA as
a starting template, on an ABI Prism 7700 sequence detec-
tion system (Applied Biosystems). The amplification pro-
gramme consisted of an initial denaturation step of 95
 
°
 
C for
10 min, followed by 40 cycles of 95
 
°
 
C for 15 s and 60
 
°
 
C for
1 min. Each sample was tested in triplicate. Results were
quantified by comparison with standard curves produced
from known copy numbers of plasmid DNAs containing
sequenced gene fragments for each of the cytokines. The effi-
ciency of RNA extraction and conversion to cDNA was
assessed by measuring the expression levels of the house-
keeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) in each of the samples.
 
Statistical analysis
 
All analysis was carried out using Microsoft® Excel 2002
(Microsoft Co., Redmond, WA, USA), Minitab™ version
13·32 (Minitab Inc., State college, PA, USA) and 
 
r
 
 (http://
www.r-project.org). Error bars indicate 
 
±
 
 standard deviation
(s.d.). For each cytokine, differences between the four animal
groups were assessed using a two-way factorial analysis of
variance (
 
anova
 
) using a model that included the interac-
tion term (vaccinated : challenged). This interaction term
determines whether prior vaccination has an effect on the
host response to infection and vice versa. The effects of each
factor were tested independently using type III sums of
squares. Where the interaction term was not significant, the
significance of each factor was taken from the 
 
anova
 
. Where
the interaction term was significant, within-group two-
sample 
 
t
 
-tests were used to assess the significance of each fac-
tor. Mann–Whitney tests were used for the comparison of
IFN-
 
γ
 
/IL-4 or IFN-
 
γ/
 
IL-10 ratios. Correlations between
cytokine expression levels were assessed by Pearson’s corre-
lation coefficient. Correlations between cytokine expression
levels and lesion scores or bacterial counts were assessed
using Spearman’s rank correlation coefficient.
 
Results
 
Suppression of cytokine expression in cattle infected 
with 
 
M. bovis
 
 compared to uninfected animals
 
Preliminary screening carried out by standard PCR indi-
cated that differences may exist between the cytokine pro-
files in the lymph nodes of the four groups of animals (data
 
Table 1.
 
Lymph node lesion scores and bacterial counts.
Vaccinated 
 
+ 
 
challenged animals
Lymph node
51 53 55 56 60
Lesion
score*
Log
 
10
 
CFU†
Lesion
score*
Log
 
10
 
CFU†
Lesion
score*
Log
 
10
 
CFU†
Lesion
score*
Log
 
10
 
CFU†
Lesion
score*
Log
 
10
 
CFU†
Parotid 0 – 0 – 0 – 0 – 1 –
Submandibular 0 – 0 – 0 – 0 – 2 2·78
Retropharyngeal left 2 3·73 0 – 2 3·67 0 3·44 0 –
Retropharyngeal right 0 – 0 – 2 3·28 0 – 0 –
Unvaccinated 
 
+ 
 
challenged animals 54 57 58 59
Lymph node Lesion
score*
Log
 
10
 
CFU†
Lesion
score*
Log
 
10
 
CFU†
Lesion
score*
Log
 
10
 
CFU†
Lesion
score*
Log
 
10
 
CFU†
Parotid 0 – 3 3·19 1 3·38 4 4·50
Submandibular 2 3·27 4 3·56 3 3·73 4 4·20
Retropharyngeal left 4 3·94 4 3·76 4 3·90 4 4·51
Retropharyngeal right 0 – 4 3·85 4 4·03 4 4·19
*Score 0–4 indicates increasing severity of lesions. †Log
 
10
 
 colony-forming units (CFU)/g of tissue; – denotes count of 
 
<
 
 500 CFU/g tissue.
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not shown). Real-time PCR was used to assess quantita-
tively expression of IL-4, IL-6, IL-10, IL-12 (p40 subunit),
TNF and IFN-
 
γ
 
 transcripts. For all cytokines, transcripts
were detected in the majority of lymph node samples exam-
ined (Fig. 1), indicating that the tissues sampled for analysis
were transcriptionally active and not subject to levels of
necrosis inhibitory to gene expression. Differences between
groups were analysed to determine whether infection, vacci-
nation or an interaction between infection and vaccination
had a significant effect on the cytokine expression level
(Table 2). Where the interaction effect was significant, dif-
ferences between groups were analysed further by within-
group two-sample 
 
t
 
-tests. In the unvaccinated group, chal-
lenge with 
 
M. bovis
 
 had a significant effect on the cytokine
expression levels within the lymph node (Fig. 1, Table 2).
We  detected  a  significant  decrease  in  expression  levels  of
IL-4 (
 
P 
 
<
 
 0·05), IL-6 (
 
P 
 
<
 
 0·001), IL-10 (
 
P 
 
< 0·001) and TNF
(P < 0·001) in challenged animals compared to unchal-
lenged animals. No significant effect of challenge was seen
for IL-12 p40 or IFN-γ expression levels in unvaccinated
animals.
Vaccinated animals display an altered response to 
challenge compared to unvaccinated animals
We also studied the response to challenge in animals that
were vaccinated with BCG prior to infection with M. bovis.
As indicated by the interaction effects seen (Table 2), vacci-
nation had a significant effect on the response to challenge.
Unlike the unvaccinated animals, vaccinated animals did not
show a decrease in IL-4 or IL-6 levels following challenge,
and showed a decrease in IFN-γ levels (P < 0·05). A compar-
ison of vaccinated challenged and unvaccinated challenged
animals indicates significantly higher levels of IL-4 in vacci-
nated animals.
Similar responses to challenge in vaccinated and unva-
ccinated animals were seen for the expression of IL-12 p40
(no change following challenge), TNF and IL-10 (decrease in
expression following challenge). However, significant differ-
ences were detected between the expression levels of IL-10 in
vaccinated challenged animals compared to unvaccinated
challenged animals. Thus, although significant decreases
were seen in IL-10 following challenge in both groups
Fig. 1. Real-time polymerase chain reaction (PCR) analysis of cytokine production by bovine lymph nodes. Interleukin (IL)-4 (a), IL-6 (b), IL-10 (c), 
tumour necrosis factor (TNF) (d), IL-12 p40 (e) and interferon (IFN)-γ (f) log(2) copy number per 100 ng lymph node cDNA starting template. , 
Unvaccinated, unchallenged animals; , vaccinated, unchallenged animals; , unvaccinated, challenged animals; , vaccinated, challenged animals. 
Results are averaged triplicate values for each lymph node sample. Error bars indicate standard deviation (s.d.) of each sample.
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(P < 0·001), there were higher levels of the cytokine in the
vaccinated animals compared to unvaccinated animals
(P = 0·004).
Correlation between cytokine gene expression levels in 
bovine lymph nodes
Results shown in Fig. 1 suggest a similar pattern of gene
expression in bovine lymph nodes following infection with
M. bovis for several of the cytokines studied. Correlation
analysis (Table 3) indicates a significant positive correlation
between the expression levels of IL-4, IL-6, IL-10 and TNF
(P < 0·05). Thus, for these cytokines, infected lymph nodes
with a high expression of one of these cytokines also showed
a high level of expression of the other three cytokines. A sig-
nificant positive correlation was also detected between the
expression levels of TNF and IFN-γ (P < 0·05).
The balance of Th1 and Th2 cytokines has a significant
impact on the immune response elicited against mycobacte-
rial infection. It was therefore important to determine the
ratio of the Th1 cytokine IFN-γ, compared to the anti-
inflammatory cytokines IL-4 and IL-10. As shown in Fig. 2,
the IFN-γ/IL-10 ratio increased significantly in both vacci-
nated (P < 0·01) and unvaccinated animals (P < 0·001) fol-
lowing challenge. However, although a significant increase in
ratio of IFN-γ/IL-4 was observed following challenge in
unvaccinated animals (P < 0·01), a significant decrease in
IFN-γ/IL-4 ratio was observed following challenge in vacci-
nated animals (P < 0·001).
The extent of pathology following infection correlates 
with cytokine expression levels within the lymph node
Correlations can be detected between the cytokine expres-
sion levels and the lesion score of the lymph nodes from
infected animals (Table 4). Assessment by Spearman’s rank
correlation coefficient showed that there was a significant
negative correlation between the expression levels of IL-4,
IL-10 and TNF and the lesion score for the lymph nodes
from infected animals. No significant correlation between
expression level and lesion score was found for IL-6, the p40
subunit of IL-12 or IFN-γ (Table 4). Similar results can be
seen for the relationship between cytokine expression levels
and the number of mycobacteria isolated from the lymph
node (Table 4). As was found for the lesion score data, there
was a significant negative correlation between bacterial
count and the transcript levels of IL-4, IL-10, and TNF. As for
the lesion scores, no significant correlation was found
between the levels of IL-6, IFN-γ or IL-12 p40 expression and
the bacterial count.
Table 2. Effect of infection and vaccination on cytokine expression 
levels.
Cytokine
Infection
effect
Vaccination
effect
Interaction
effect
IL-4 < 0·001 0·484 < 0·001
IL-6 < 0·001 0·633  0·048
IL-10 < 0·001 0·004  0·917
TNF < 0·001 0·105  0·193
IL-12 p40  0·059 0·308  0·847
IFN-γ  0·007 0·942  0·040
Figures indicate P-values for the effect of infection, vaccination or
an interaction between the two factors on the cytokine expression level
per animal. Bold type indicates significance (P < 0·05). IL: interleukin;
IFN: interferon; TNF: tumour necrosis factor.
Fig. 2. Th1/Th2 bias in bovine lymph nodes fol-
lowing challenge with Mycobacterium bovis. 
Ratio of interferon (IFN)-γ/interleukin (IL)-4 (a) 
and IFN-γ/IL-10 (b) copy number per 100 ng 
lymph node cDNA starting template. , Unvac-
cinated, unchallenged animals; , unvaccinated, 
challenged animals; , vaccinated, unchallenged 
animals; , vaccinated, challenged animals. 
Results are averaged triplicate values for each 
lymph node sample. *P < 0·01, **P < 0·001 by 
Mann–Whitney tests.
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Table 3. Correlation of cytokine expression levels in bovine lymph 
nodes.
IL-4 IL-6 IL-10 TNF IL-12 p40
IL-6  0·409
 0·020
IL-10  0·557  0·432
 0·001  0·014
TNF  0·741  0·466  0·597
< 0·001  0·007 < 0·001
IL-12 p40 − 0·163 − 0·198 − 0·053 0·078
 0·371  0·278  0·774 0·673
IFN-γ − 0·182 − 0·053 − 0·009 0·366 0·258
 0·319  0·772  0·962 0·040 0·154
Top value: Pearson correlation score; bottom value: P-value. Bold
type indicates significance (P < 0·05). IL: interleukin; IFN: interferon;
TNF: tumour necrosis factor.
S. Widdison et al.
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Discussion
In this study we analysed the cytokine gene expression pro-
files of lymph nodes draining the area of infection in cattle
challenged intranasally with M. bovis and compared them to
levels in uninfected cattle. In addition, the effects of vacci-
nation with M. bovis BCG on cytokine expression in both
healthy and challenged animals were examined. The model
allowed the analysis of events in local tissues at a time when
a chronic infection was becoming established, after the acute
early stage of infection when bacterial replication is extensive
and after the induction of an immune response, evident
from about 2–3 weeks post-infection [36]. There are few
quantitative data describing cytokine gene expression from
models of TB examined at this disease point. In human stud-
ies it is impossible to establish the length of time for which
disease has been established. Studies have been carried out in
mice, but here granuloma formation does not involve
caseation and necrosis [27]. The model used here provided
data from a natural host and pathogen that is relevant to
understanding the development of chronic and persistent
granulomas.
Using quantitative PCR, we detected a significant decrease
in the expression levels of IL-4, IL-6, IL-10 and TNF in chal-
lenged animals compared to unchallenged animals, indicat-
ing suppression of these elements of the immune response as
a result of the infection. A reduction or complete absence of
cytokines in tissue infected with mycobacteria has been
observed previously both in cattle, for example during M.
avium ssp. paratuberculosis infection [37], and in other spe-
cies [24,25]. One study of tissue biopsies from the lungs of
TB patients detected no TNF, IFN-γ or IL-4 in the samples
[24], while another showed a marked reduction in IL-10 and
IL-4 expression [25]. These and other studies indicate, there-
fore, that detection of cytokine expression in healthy tissue is
not unusual [25,37,38].
The number of transcripts encoding the pro-inflammatory
cytokines IFN-γ and IL-12 were not reduced in the lymph
nodes of challenged animals. This may relate to the time-
point at which samples were taken. Seventy days after BCG
infection of mice, the initial increases seen in IFN-γ and IL-
12 mRNA were returning to baseline levels [39]. A second
study of IFN-γ levels in the peripheral blood of cattle infected
with M. bovis showed that at 12 weeks post-infection, while
IFN-γ protein levels were still elevated, mRNA levels were
similar to those seen prior to infection [40]. IFN-γ and IL-12
are crucial for immunity to mycobacteria as they activate Mφ
to produce other cytokines and release nitric oxide to kill
intracellular mycobacteria [10,41,42] and promote phagoso-
mal acidification, counteracting intracellular persistence
[43,44]. The maintenance of this response is therefore of
obvious benefit to the host, and results in a strong Th1 bias
in infected lymph nodes, as was observed. Whether down-
regulation of IL-4 and IL-10 expression by the host supports
the maintenance of IL-12 and IFN-γ synthesis, or if the active
maintenance of IL-12 and IFN-γ responses by the host results
in the suppression of IL-4 and IL-10 expression cannot be
determined. The suppressed levels of IL-4, IL-6, IL-10 and
TNF in infected animals in comparison to maintenance of IL-
12 and IFN-γ indicates a specificity in the suppression, not a
generalized consequence of infection and necrosis due to the
developing chronic immune response.
TNF is known to act in conjunction with IFN-γ to induce
the release of reactive oxygen and nitrogen species in infected
Mφ [16,17]. However, although TNF has many beneficial
effects and is thought to limit inflammation early on in dis-
ease [16,45], it can become toxic at high concentrations dur-
ing disease progression, through an increase in necrosis and
tissue damage, particularly in sites with a Th0 or Th2 profile
characterized by the production of IL-4 [46,47]. The
observed down-regulation of TNF following challenge may
thus be a response initiated by the host to attempt to control
the level of tissue destruction occurring, although it could
also benefit mycobacterial persistence as a result of decreased
production of reactive oxygen and nitrogen intermediates.
Down-regulation of the anti-inflammatory IL-4 and IL-10
response in infected animal tissues is likely to relate to the
role of these two cytokines in the regulation of granuloma
size and necrosis, as well as preventing tissue damage
through  the  regulation  of  type  I  cytokine  production
[48–54]. IL-4 can be transcribed as a splice variant, IL-4δ2,
which acts as an antagonist of IL-4 activity in mice and
humans [55,56]; however, its role in cattle immunity is
unknown and was not included as part of this study.
Table 4. Correlation of cytokine expression levels and pathology in infected animals.
Cytokine 
Lesion score Bacterial count
Spearman’s rank
correlation coefficient P-value
Spearman’s rank
correlation coefficient P-value
IL-4 − 0·715 < 0·001 − 0·715 < 0·001
IL-6 − 0·261  0·130 − 0·261  0·130
IL-10 − 0·400  0·018 − 0·400  0·018
TNF − 0·571 < 0·001 − 0·571 < 0·001
IL-12 p40  0·139  0·423  0·139  0·423
IFN-γ  0·18  0·299  0·18  0·299
Bold type indicates significance (P < 0·05). IL: interleukin; IFN: interferon; TNF: tumour necrosis factor.
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The observed negative correlation between the Th2 cytok-
ines IL-4 and IL-10 and the pathology score is unsurprising
given their role in limiting tissue destruction, thus smaller,
less necrotic lesions show the highest levels of these anti-
inflammatory cytokines. The inverse correlation between
bacterial load and Th2 cytokine expression may relate to
their role in suppressing pro-inflammatory cytokine expres-
sion [11–13]. These cytokines may be down-regulated
actively in lesions with a high bacterial load to allow main-
tenance of the pro-inflammatory response and killing of
mycobacteria. We also detected an inverse correlation
between TNF expression and pathology score. This is more
surprising as TNF, like other pro-inflammatory cytokines,
has a role in mycobacterial killing [16,45]. However, an
inverse correlation between increased pathology and TNF
production has been described previously in a mouse model
of tuberculosis [38]. This is thought to relate to an increase
in the levels of TGF-β, which acts to decrease TNF produc-
tion [38,57].
A number of studies have related the extent of lesions at
necroscopy to the amount of IFN-γ detected by enzyme-
linked immunosorbent assay in restimulated blood cells
from cattle infected in the respiratory tract with M. bovis
[29,40,58–60]. Studies have shown that IFN-γ levels in
restimulation assays of blood cells correlate with that in
infected lymph nodes [29,58–60]. However, no positive or
negative correlation has been shown for IL-4 or IL-10 pro-
tein levels in the periphery and at the site of the disease; in
fact, IL-10 appears to correlate broadly with IFN-γ in sup-
ernatants from restimulated lymphocytes [61], and IL-4 is
not always detected [29,58,62]. Discrepancies in immune
responses to mycobacteria at the site of disease and in the
periphery have been reported elsewhere [13,63].
Vaccination of cattle prior to infection with pathogenic
mycobacteria lowered significantly the extent of granuloma
formation and the number of bacteria isolated from the
node [29]. We hypothesized that the differences seen in
pathology would be reflected in the cytokine expression pro-
files of vaccinated animals and found that vaccinated ani-
mals did not show the decrease in IL-4 and IL-6 levels
observed in unvaccinated animals following challenge.
Instead, the levels of these two cytokines were maintained.
Following challenge, IL-4 and IL-10 expression levels were
also higher in the vaccinated animals compared to unv-
accinated animals. In addition, contrary to what was found
in unvaccinated animals following challenge, vaccinated
animals showed decreased levels of IFN-γ expression in
response to infection. These changes in expression of pro-
and anti-inflammatory cytokines in vaccinated animals are
reflected in the Th1/Th2 bias of the immune response, as evi-
denced in the IFN-γ/IL-4 ratio. Unlike the unvaccinated
animals, which developed a strong Th1 bias in response to
M. bovis infection, the vaccinated animals had lower levels of
IFN-γ expression in comparison to IL-4. The down-regula-
tion of the pro-inflammatory response and up-regulation of
the anti-inflammatory response correlates with the reduced
bacterial load and restricted granuloma formation observed
in vaccinated animals. Thus a likely scenario is that the
decreased bacterial load results in a less potent IFN-γ
response and consequently less suppression of IL-4 synthesis
occurs.
In this study we measured cytokine expression levels only
at 16 weeks post-infection. The time of sampling can have a
significant impact on the levels of cytokines present, as the
cytokine response to mycobacterial infection, at least in
other species, is dynamic. During the early Th1 response to
mycobacterial infection in mice IFN-γ is the predominant
cytokine, then the response shifts to a combined IFN-γ and
IL-4 mediated response, and subsequently an IL-4 dominant
Th2 response as infection progresses [14,64]. Patterns of
cytokine expression have also been described in cattle
[40,62,65] and an antibody response is evident in the later
stages of chronic disease that may be related to a Th0/Th2
shift in the immune response [36,40]. Results reported here
support this, as at 4 months post-infection unvaccinated cat-
tle show a strong Th1 bias, whereas vaccinated cattle exhibit
a more Th0-type profile.
We  propose  that  in  unvaccinated  cattle  challenged  with
M. bovis the cytokine response in the lymph nodes is pre-
dominantly pro-inflammatory, as indicated by the decreased
expression levels of the anti-inflammatory cytokines IL-4
and IL-10 compared to the maintenance of IFN-γ and IL-12.
In the case of IL-4 and IL-10, the levels of suppression can be
correlated directly with the level of pathology and bacterial
burden of the lymph node, indicating a direct response to
infection. The pro-inflammatory response, while necessary
for infection control, is deleterious to the host as increased
tissue-damage occurs. In contrast, animals vaccinated with
BCG prior to M. bovis challenge show reduced pathology in
the lymph nodes, relating to a decreased bacterial burden
and a consequent Th0-type immune response.
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